Cabaletta Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cabaletta Bio generated cash of -$53,549,000, which is less than the previous year. Cash used in financing activities reached the amount of $187,631,000 last year. Net change in cash is therefore $111,631,000.
Cash Flow
| 2017 | 0 | 0 | 1.33K |
|---|---|---|---|
| 2018 | -4.66M | 0 | 37.67M |
| 2019 | -16.04M | -693K | 119.92M |
| 2020 | -26.77M | -7.98M | -24K |
| 2021 | -34.10M | 5.99M | 48.90M |
| 2022 | -46.38M | -27.21M | 32.98M |
| 2023 | -53.54M | -22.45M | 187.63M |
CABA Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 81.60M | 122.22M | 101.42M | 136.20M | 33.01M | 1K | -1.33K |
Operating activities | |||||||
Net income | -67.67M | -52.97M | -46.28M | -33.33M | -16.94M | -12.20M | -333.33K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 1.42M | 1.17M | 733K | 354K | 104K | 0 | 0 |
Stock-based compensation expense | 11.34M | 6.89M | 5.80M | 4.38M | 2.3M | 0 | 0 |
| Deferred income tax benefit | 11.34M | 6.89M | 5.80M | 4.38M | 2.3M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.67M | -28K | 975K | 555K | 246K | 234K | 0 |
Cash generated by operating activities | -53.54M | -46.38M | -34.10M | -26.77M | -16.04M | -4.66M | 0 |
Investing activities | |||||||
Purchases Of Investments | -84.26M | -49.76M | 0 | -11.09M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -687K | -2.45M | -1.16M | -635K | -693K | 0 | 0 |
Acquisitions Net | 0 | 24.76K | 0 | 7.34K | 0 | 0 | 0 |
Cash generated by investing activities | -22.45M | -27.21M | 5.99M | -7.98M | -693K | 0 | 0 |
Financing activities | |||||||
Common Stock Issued | 185.20M | 32.85M | 48.90M | 29K | 71.21M | 25.14M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -10.09M | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -192K | 0 | -169K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -12.53M | 0 |
Cash used in financing activities | 187.63M | 32.98M | 48.90M | -24K | 119.92M | 37.67M | 1.33K |
Net Change In Cash | 111.63M | -40.61M | 20.79M | -34.77M | 103.18M | 33.01M | 1.33K |
Cash at end of period | 193.23M | 81.60M | 122.22M | 101.42M | 136.20M | 33.01M | 1 |
| Data source | Data source | Data source | Data source | Data source |